BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 9316767)

  • 1. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features, pathogenesis, and treatment of Sjögren's syndrome.
    Fox RI
    Curr Opin Rheumatol; 1996 Sep; 8(5):438-45. PubMed ID: 8941447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and Sjögren syndrome.
    Manganelli P; Fietta P
    Semin Arthritis Rheum; 2003 Aug; 33(1):49-65. PubMed ID: 12920696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome in dermatology.
    Fox RI; Liu AY
    Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Criteria for diagnosis of Sjögren's syndrome.
    Fox RI; Saito I
    Rheum Dis Clin North Am; 1994 May; 20(2):391-407. PubMed ID: 8016418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of Sjögren's syndrome.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
    Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of apoptotic protease cascade for tissue destruction in Sjögren's syndrome.
    Hayashi Y; Yayagi K; Haneji N
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):399-403. PubMed ID: 11140467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of caspase cascade on the development of primary Sjögren's syndrome.
    Hayashi Y; Arakaki R; Ishimaru N
    J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome?
    Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J
    Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
    Abu-Helu RF; Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2001 Sep; 17(2):141-53. PubMed ID: 11591123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sjögren's syndrome: viewpoint on pathogenesis. One of the reasons I was never asked to write a textbook chapter on it.
    Konttinen YT; Käsnä-Ronkainen L
    Scand J Rheumatol Suppl; 2002; 116():15-22. PubMed ID: 12109538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
    De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
    Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
    Tzioufas AG; Voulgarelis M
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
    Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
    Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary diagnostic criteria for Sjögren's syndrome.
    Skopouli FN; Drosos AA; Papaioannou T; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():22-5. PubMed ID: 3473635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.